MedPath
Found 1146 clinical trials|View Analysis
Sort by:

CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: a Dose Escalation Phase I Trial

Early Phase 1
Recruiting
Conditions
Leukemia, Myeloid, Acute(AML)
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Myelodysplastic Syndromes (MDS)
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Interventions
Biological: Autologous CAR123 T lymphocytes
First Posted Date
2025-01-09
Last Posted Date
2025-01-09
Lead Sponsor
Institute of Hematology and Blood Transfusion, Czech Republic
Target Recruit Count
18
Registration Number
NCT06765876
Locations
🇨🇿

Ustav hematologie a krevni transfuze / Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Comparison of the Performance and Effectiveness of Two Transfusion-Saving Devices: Cell-Saver and SAME

Completed
Conditions
Cardiac Surgery Under Extra Corporeal Circulation
Cardiac Surgery Requiring Cardiopulmonary Bypass
First Posted Date
2025-01-09
Last Posted Date
2025-01-09
Lead Sponsor
Nantes University Hospital
Target Recruit Count
304
Registration Number
NCT06766032
Locations
🇫🇷

CHU de Nantes, Nantes, France

Assessment of a Quantra-guided Transfusion Algorithm in Liver Transplantation

Not Applicable
Not yet recruiting
Conditions
Liver Transplantation
Interventions
Biological: Transfusion algorithm based on Quantra®
Biological: Conventional transfusion algorithm
First Posted Date
2024-12-27
Last Posted Date
2024-12-27
Lead Sponsor
University Hospital, Toulouse
Target Recruit Count
56
Registration Number
NCT06749405
Locations
🇫🇷

Toulouse University Hospital, Toulouse, France

Modeling Blood Management and Hemolytic Risk in Pediatric Heart Surgery

Not yet recruiting
Conditions
Heart Surgery
Blood Transfusion
Hemolysis
First Posted Date
2024-12-06
Last Posted Date
2024-12-06
Lead Sponsor
Boston Children's Hospital
Target Recruit Count
50
Registration Number
NCT06721455
Locations
🇺🇸

Boston Children's Hospital, Boston, Massachusetts, United States

Hemoglobin Levels for Blood Transfusions During and After Surgery

Not Applicable
Not yet recruiting
Conditions
Blood Transfusion
Surgery
First Posted Date
2024-12-05
Last Posted Date
2024-12-05
Lead Sponsor
Ottawa Hospital Research Institute
Target Recruit Count
384
Registration Number
NCT06718439
Locations
🇨🇦

The Ottawa Hospital, Ottawa, Ontario, Canada

Efficacy of Intraoperative Periarticular Injections in Hip Fracture Hemiarthroplasty

Not Applicable
Completed
Conditions
Femoral Neck Fractures
Hemiarthroplasty
Blood Loss Requiring Transfusion
First Posted Date
2024-11-22
Last Posted Date
2024-11-25
Lead Sponsor
Ankara City Hospital Bilkent
Target Recruit Count
84
Registration Number
NCT06701695
Locations
🇹🇷

Ankara Bilkent City Hospital, Ankara, Turkey

A Nomogram Predicting the Risk of High-dose Transfusion in Non-cardiac Surgery

Completed
Conditions
Massive Transfusion
Nomogram Model
First Posted Date
2024-11-22
Last Posted Date
2024-11-22
Lead Sponsor
West China Hospital
Target Recruit Count
11197
Registration Number
NCT06701747
Locations
🇨🇳

West China Hospital, Sichuan University, Chengdu, Sichuan, China

Antibiotic Concentrations After MassivE Transfusion Study

Recruiting
Conditions
Adverse Effects in the Therapeutic Use of Other and Unspecified Agents Affecting Blood Constituents
First Posted Date
2024-11-21
Last Posted Date
2024-11-21
Lead Sponsor
Brooke Army Medical Center
Target Recruit Count
417
Registration Number
NCT06699901
Locations
🇺🇸

University of Colorado Hospital, Aurora, Colorado, United States

🇺🇸

Brooke Army Medical Center, Fort Sam Houston, Texas, United States

Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion

Not Applicable
Recruiting
Conditions
Hematologic Neoplasms
First Posted Date
2024-11-13
Last Posted Date
2024-12-10
Lead Sponsor
Hemanext
Target Recruit Count
24
Registration Number
NCT06685848
Locations
🇳🇴

Haukeland University Hospital, Bergen, Norway

A Pilot Study on the Safety and Efficacy of YOLT-204 for Transfusion-Dependent Beta-Thalassemia

Early Phase 1
Not yet recruiting
Conditions
Transfusion Dependent Beta Thalassemia
Interventions
Drug: YOLT-204
First Posted Date
2024-11-07
Last Posted Date
2024-11-07
Lead Sponsor
First Affiliated Hospital of Guangxi Medical University
Target Recruit Count
3
Registration Number
NCT06678165
Locations
🇨🇳

The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China

© Copyright 2025. All Rights Reserved by MedPath